Preview

Journal Infectology

Advanced search

Endobronchial Manifestations of the Novel Coronavirus Infection (COVID-19): Data from the Endoscopy Unit of a COVID-19 Hospital

https://doi.org/10.22625/2072-6732-2025-17-2-80-88

Abstract

Study objective. To identify features of endobronchial symptoms, includingincluding whether there is a relationship between the characteristics of endobronchial findings and the predominance of a particular COVID-19 viral strain during specific time intervals.
Materials and methods. This study analyzed the results of 668 (100%) initial bronchoscopies performed in patients with COVID-19. All procedures were carried out in an endoscopy unit or intensive care setting. To assess the frequency of various events, the chi-square (χ2) test was used to evaluate the equality of proportions, with a significance level of p = 0.05.
Results. Two distinct time periods were provisionally identified, differing in endobronchial symptomatology. During the first period, the predominant circulating strains of COVID-19 were Alpha, Beta, Gamma and Delta. The onset of the second period approximately coincided with the dominance of the Omicron variant. In the first time period (278 primary bronchoscopies, 41.617%), inflammatory changes of the bronchial mucosa were mild, and hemorrhagic endobronchial syndrome was frequently observed. There were 4 cases (0.599%) of endobronchial ulcers requiring morphological and bacteriological verification. A purulent component of endobronchial inflammation was rare (14 cases, 2.096%) and occurred only in the presence of pre-existing bronchial obstructive disease. In the second time period, purulent inflammation became widespread, while hemorrhagic endobronchial syndrome nearly completely resolved. In most cases, bronchial obstruction during this period was directly attributable to COVID-19. All observed differences were statistically significant.
Conclusion. Endobronchial findings in patients with COVID-19 are nonspecific, lack pathognomonic features and generally align with the typical presentation of endobronchitis. Prior to the emergence of the Omicron variant, the endobronchial picture was characterized by mild inflammatory changes and hemorrhagic endobronchial syndrome. During the Omicron-dominant period, inflammatory changes intensified against the backdrop of an almost complete resolution of hemorrhagic endobronchial syndrome.

About the Authors

M. L. Shteiner
Samara City Hospital № 4; Samara State Medical University
Russian Federation

Samara



Yu. I. Biktagirov
Samara State Medical University
Russian Federation

Samara



A. V. Zhestkov
Medical University «REAVIZ»
Russian Federation

Samara



E. V. Makova
Samara City Hospital № 4; Medical University «REAVIZ»
Russian Federation

Samara



References

1. Russkikh A.A., Luk’yanenko N.V., Luk’yanenko N.YA., Petrova A.A. Otsenka fakto-rov riska rasprostraneniya COVID-19 personalom v reanimatsionnykh otdeleniyakh mnogo profil’nogo statsionara. Permskiy meditsinskiy zhurnal. 2023; XL (2). 92-99. https://doi.org/10.17816/pmj40292%99.

2. Repichi A., Nikonov Ye.L., Kashin S.V., Kuvayev R.O., Rezvaya A.A. Koronavirusnaya infektsiya: infektsionnaya bezopasnost’ v endoskopicheskom otdelenii. Dokazatel’naya gastroenterologiya. 2020; 9 (1): С. 5-13. https://doi.org/10.17116/dokgastro202090115.

3. Wahidi M.M., Lamb C., Murgu S., Musani A., Shojaee S., Sachdeva A., Maldonado F., Mahmood K., Kinsey M., Sethi S., Mahajan A., Majid A, Keyes C., Alraiyes A.H., Sung A., Hsia D., Eapen G. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection. J. Bronchology Interv. Pulmonol. 2020; 27 (4): 52-54. https://doi.org/10.1097/LBR.0000000000000681.

4. Reddy P.D., Nguyen S.A., Deschler D. Bronchoscopy, Laryngoscopy, and Esophagoscopy During the COVID-19 Pandemic. Head & Neck. 2020; 10: 1-4. https: //doi.org/10.1002/hed.26221.

5. Klein U., Karzai W., Zimmerman P., Hanneman U., Koschel U. Changes in pulmonary Mechanics after Fiberoptic Bronchoalveolar Lavage in mechanically ventilated Patients. Intensive Care Med. 1998; 24 (12). 1289-1293. https://doi.org/10.1007/s001340050764.

6. Yershov A.L. Obespecheniye prokhodimosti dykhatel’nykh putey pri ostroy dykha-tel’noy nedostatochnosti vne statsionara. Skoraya meditsinskaya pomoshch’. 2018; 3. 62-69. https://doi.org/10.24884/2072-6716-2018-19-3-62-69.

7. Андреенко А.А., Долбнева Е.А., Стамов В.И. Обеспечение проходимости верхних дыхательных путей в стационаре. Клинические рекомендации Федерации анестезиологов и реаниматологов (второй пересмотр, 2018 г.). Вестник интенсивной терапии им. С.А. Салтанова. 2019; 2. 7-31. https://doi.org/10.21320/1818-474X-2019-2-7-7-31.

8. Tomassetti S., Ciani L., Luzzi V., Gori L.,Trigiani M., Giuntoli L., Lavorini F., Poletti V., Ravaglia C., Torrego A., Maldonado F., Lentz R., Annunziato F., Maggi L., Rossolini G.M., Pollini S., Para O., Ciurleo G., Casini A., Rasero L., Bartoloni A., Spinicci M., Munavvar M., Gasparini S., Comin C., Cerinic M.M., Peired A., Henket M., Ernst B., Louis R., Corhay J-L., C. Nardi, Guiot J. Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium. Front Med (Lausanne). 2024;.11: 1259570. https://doi.org/10.3389/fmed.2024.1259570.

9. Liao M., Liu Y., Yuan J., Wen Y., Xu G., Zhao J., Cheng L., Li J., Wang X., Wang F., Liu L., Amit I., Zhang S., Zhang Z. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020; 26 (6): 842-844. https://doi.org/10.1038/s41591-020-0901-9.

10. Perevezentsev O.A., Kholodnaya T.O., Samsonov A.E., Burtsev D.V. Metody spetsificheskogo laboratornogo testirovaniya novoy koronavirusnoy infektsii. Meditsinskiy vestnik Yuga Rossii. 2020; 11 (3). 27-33 https://doi.org/10.21886/2219-8075-2020-11-3-27-33.

11. Yakovlev V.N., Alekseyev V.G. Bronkhologicheskiye metody diagnostiki i lecheniya v praktike pul’monologa. Moskva: Nauka. 2013. 256.

12. Chernichenko N.V. Diagnosticheskaya bronkhoskopiya (v rukovodstve po respirator-noy meditsine pod red. A.G. Chuchalina (2-ye izdaniye, pererab. i dop.). Moskva: Littera. 2017. I. 302-314.

13. Dimopoulos G., Almyroudi M.P., Myrianthefs P., Rello J. COVID-19-Associated Pulmonary Aspergillosis (CAPA). J. Intensive Med. 2021; 1 (2): 71-80. https://doi.org/10.1016/j.jointm.2021.07.001.

14. Tereshchenko S.G., Bogdanov A.M., Mecheva L.V. Opyt diagnosticheskoy i lechebnoy bronkhoskopii u bol’nykh s koronavirusnoy infektsiyey. Endoskopicheskaya khirurgiya. 2021; 27 (4): 23-29. https://doi.org/10.17116/endoskop20212704123.

15. Bruyneel M., Gabrovska M., Rummens P., Roman A., Claus M., Stevens E., Dechamps P., Demey L., Truffaut L., Ninane V. Bronchoscopy in COVID-19 intensive care unit patients. Respirology. 2020; 25(12): 1313-1315. https://doi.org/10.1111/resp.13932.

16. Omarova KH.Z., Magomedova S.A., Dolgatov G.M., Ambegov G.M., Isayeva S.D. Endoskopicheskoye posobiye pri sanatsii trakheobronkhial’nogo dereva u patsiyentov v usloviyakh reanimatsionnogo otdeleniya s koronavirusnoy infektsiyey SOVIL-19. V sbornike: ″Sbornik nauchnykh trudov, posvyashchonnykh 90-letiyu so dnya obrazovaniya FGBOU VO ″Dagestanskiy gosudarstvennyy meditsinskiy universitet″ Minzdrava Rossii″. Makhachkala. 2022. 279-281.

17. Lukomskiy G.I., Shulutko M.L., Vinner M.G., Smetnov A.S. Бронхология. Moskva: Meditsina. 1973. 359.

18. Shteyner M.L., Zhestkov A.V., Biktagirov YU.I., Babanov S.A., Korymasov Ye.A., Krivoshchokov Ye.P., Protasov A.D., Kozlova O.S., Kulagina V.V., Khuras’kina T.P. Gemorragicheskiy endobronkhial’nyy sindrom v pul’monologicheskoy praktike: dannyye bronkhoskopii. Vrach. 2020; 31 (7): 36-40. https://doi.org/10.29296/25877305-2020-07.

19. Richardson J.T.E. The analysis of 2 x 2 contingency tables – Yet again. Stat. Med. 2011; 30 (8): 890. https://doi.org/10.1002/sim.4116.

20. Ofitsial’nyy sayt zdravookhraneniya Rossiyskoy Federatsii. [Elektronnyy resurs] – Rezhim dostup: https://minzdrav.gov.ru/

21. Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395 (10234): 1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5.

22. Suh J., Mukerji S.S., Collens S.I., Padera Jr. R.F., Pinkus G.S., Amato A.A., Solomon I.H. Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19. Neurology. 2021; 97 (8): 849-858. https://doi.org/10.1212/WNL.0000000000012344.


Review

For citations:


Shteiner M.L., Biktagirov Yu.I., Zhestkov A.V., Makova E.V. Endobronchial Manifestations of the Novel Coronavirus Infection (COVID-19): Data from the Endoscopy Unit of a COVID-19 Hospital. Journal Infectology. 2025;17(2):80-88. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-2-80-88

Views: 70


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)